Fig 1.
Frequency of clinical forms in patients with chronic dC, who underwent benznidazole treatment.
Table 1.
Values of liver enzymes in patients using benznidazole for Chagas’s disease specific treatment.
Fig 2.
Frequency of adverse events to benznidazole.
Table 2.
Liver enzymes elevation and presence of other adverse events to benznidazole in literature reports.